Physician profile
Hunter Ford
NPI 1699346643
$2,823.87
in general payments reported to CMS, 2019-2025
6 companies · $922 in 2025
The $922 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $335 · 2024: $1,567 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.87 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,722.22 | 2023-2025 | Endurant Iis, In.Pact Admiral, Valiant Captivia |
| Shockwave Medical, INC | $842.39 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Dilon Technologies, INC. | $116.66 | 2023 | Hemoblast Bellows |
| Terumo Medical Corporation | $86.45 | 2024-2025 | Glidesheath Slender, Azur Cx Detachable, Tr Band |
| Stryker Corporation | $40.75 | 2025 | Artix Mt |
| Mimedx Group, INC. | $15.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.